I agree that this site is using cookies. You can find further informations here.
X
Ishibashi, Mariko
136  results:
Search for persons X
?
1

The levels of serum soluble CD86 are correlated with the ex..:

Kinoshita, Ryosuke ; Ishibashi, Mariko ; Handa, Hiroshi...
Experimental Hematology.  121 (2023)  - p. 38-47.e2 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Current and Future PET Imaging for Multiple Myeloma:

Ishibashi, Mariko ; Takahashi, Miwako ; Yamaya, Taiga.
Life.  13 (2023)  8 - p. 1701 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Clinicopathologic Characteristics and A20 Mutation in Prima..:

Kuribayashi-Hamada, Yasuko ; Ishibashi, Mariko ; Tatsuguchi, Atsushi...
Journal of Nippon Medical School.  89 (2022)  3 - p. 301-308 , 2022
Link: https://doi.org/10.1272/..
 
?
4

Epigenetic Priming with Decitabine Augments the Therapeutic..:

Nakajima, Wataru ; Miyazaki, Kai ; Sakaguchi, Masahiro...
Cancers.  14 (2022)  1 - p. 248 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Immune Functions of Signaling Lymphocytic Activation Molecu..:

Ishibashi, Mariko ; Morita, Rimpei ; Tamura, Hideto
Cancers.  13 (2021)  2 - p. 279 , 2021
Link: https://doi.org/10.3390/..
 
?
6

The SLAMF3 rs509749 polymorphism correlates with malignant ..:

Ishibashi, Mariko ; Sunakawa-Kii, Mika ; Kaito, Yuta...
Experimental Hematology.  90 (2020)  - p. 72-79 , 2020
Link: https://doi.org/10.1016/..
 
?
7

PD-L1–PD-1 Pathway in the Pathophysiology of Multiple Myelo..:

Tamura, Hideto ; Ishibashi, Mariko ; Sunakawa-Kii, Mika.
Cancers.  12 (2020)  4 - p. 924 , 2020
Link: https://doi.org/10.3390/..
 
?
8

Immunotherapy for Multiple Myeloma:

Tamura, Hideto ; Ishibashi, Mariko ; Sunakawa, Mika.
Cancers.  11 (2019)  12 - p. 2009 , 2019
Link: https://doi.org/10.3390/..
 
?
9

Clinical impact of serum soluble SLAMF7 in multiple myeloma:

Ishibashi, Mariko ; Soeda, Saori ; Sasaki, Makoto...
Oncotarget.  9 (2018)  78 - p. 34784-34793 , 2018
Link: https://doi.org/10.18632..
 
?
10

Clinical Impact and Possible Immunosuppressive Function of ..:

Sunakawa, Mika ; Tamura, Hideto ; Ishibashi, Mariko...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e110-e111 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Functional expression of Tim-3 on blasts and clinical impac..:

Asayama, Toshio ; Tamura, Hideto ; Ishibashi, Mariko...
Oncotarget.  8 (2017)  51 - p. 88904-88917 , 2017
Link: https://doi.org/10.18632..
 
?
12

Serum Soluble SLAMF7 is Correlated With Disease Progression..:

Kaito, Yuta ; Tamura, Hideto ; Soeda, Saori...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e39-e40 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Contradictory intrahepatic immune responses activated in hi..:

Ishibashi, Mariko ; Yamaguchi, Hiromi ; Hirotani, Yukari...
Archives of Virology.  163 (2017)  4 - p. 855-865 , 2017
Link: https://doi.org/10.1007/..
 
?
14

Transmembrane serine protease TMPRSS2 activates hepatitis C..:

Esumi, Mariko ; Ishibashi, Mariko ; Yamaguchi, Hiromi...
Hepatology.  61 (2015)  2 - p. 437-446 , 2015
Link: https://doi.org/10.1002/..
 
?
15

CLEC4M-positive and CD81-negative Huh7 cells are not suscep..:

Ishibashi, Mariko ; Morita, Naoko ; Nomura-Kawaguchi, Chisato...
Archives of Virology.  159 (2014)  11 - p. 2949-2955 , 2014
Link: https://doi.org/10.1007/..
 
1-15